MCP-1/CCL2 as a Therapeutic Target in Myocardial Infarction and Ischemic Cardiomyopathy

E-ISSN： 2212-4055|6|2|101-107

ISSN： 1871-5281

Source： Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol.6, Iss.2, 2007-06, pp. : 101-107

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Mast Cell: A Potential Therapeutic Target in Myocardial Infarction

Drug Design Reviews - Online, Vol. 2, Iss. 3, 2005-05 ,pp. : 219-225

Bentham Science Publishers

Access to resources Recommend Favorite

Macrophage Polarization as a Therapeutic Target in Myocardial Infarction

Current Drug Targets, Vol. 19, Iss. 6, 2018-04 ,pp. : 651-662

Bentham Science Publishers

Access to resources Recommend Favorite

Fibrosis as a Therapeutic Target Post-Myocardial Infarction

Current Pharmaceutical Design, Vol. 11, Iss. 4, 2005-02 ,pp. : 477-487

Bentham Science Publishers

Access to resources Recommend Favorite

Selective Elevation of Circulating CCL2/MCP1 Levels in Patients with Longstanding Post-vaccinal Macrophagic Myofasciitis and ASIA

Current Medicinal Chemistry, Vol. 21, Iss. 4, 2014-02 ,pp. : 511-517

Bentham Science Publishers

Access to resources Recommend Favorite

GLT-1 Upregulation as a Potential Therapeutic Target for Ischemic Brain Injury

Current Pharmaceutical Design, Vol. 23, Iss. 33, 2018-01 ,pp. : 5045-5055

Bentham Science Publishers

Access to resources Recommend Favorite